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STATE-OF-THE-ART PAPERDSTATE-OF-THE-ART PAPER223Cardiovascular Risk Assessment of the Liver Transplant CandidateZankhana Raval, Matthew E. Harinstein, Anton I. Skaro, Ata Erdogan, Andre M. DeWolf, Sanjiv J. Shah,
Oren K. Fix, Nina Kay, Michael I. Abecassis, Mihai Gheorghiade, James D. Flaherty
Patients undergoing liver transplantation are at risk for several cardiovascular complications.
Raval and colleagues review these potential complications and provide specific recommenda-
tions for the pre-operative cardiovascular assessment of liver transplant candidates. Among the
recommendations, angiography should be performed in patients with risk factors for coronary
artery disease because of the reduced sensitivity of pharmacologic stress testing in patients
with liver disease. Echocardiography should be performed to assess left and right ventricular
size and function, valvular function, and pulmonary artery pressure, and to exclude the
presence of a significant pericardial effusion.MINI-FOCUS:
ADIPOSE INFLAMMATION
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232egree of Adipose Tissue Inflammation
Correlates With Obesity-Related Cardiac Risk FactorsMelissa G. Farb, Sherman Bigornia, Melanie Mott, Kahraman Tanriverdi, Kristine M. Morin,
Jane E. Freedman, Lija Joseph, Donald T. Hess, Caroline M. Apovian, Joseph A. Vita, Noyan Gokce
Farb and colleagues investigated the relationship between adipose tissue inflammation in
obese individuals and cardiometabolic disease. Subcutaneous abdominal fat biopsies were
obtained from obese and lean subjects; obese subjects were then categorized based on the
presence () or absence () of macrophage crown-like structures (CLS), which are signs
of adipocyte inflammation. Inflamed CLS obese individuals displayed higher plasma
insulin, homeostasis model assessment, triglycerides, glucose, blood pressure, high-sensitivity
C-reactive protein, and low-density lipoprotein cholesterol, and lower high-density lipoprotein
cholesterol and brachial artery flow-mediated dilation compared with lean subjects. Obese
subjects with noninflamed fat were intermediate to lean and CLS subjects. These findings
suggest that qualitative features of adipose tissue, such as the degree of inflammation, may
modify its toxicity and may therefore be targets for therapeutic modulation.(continued on page A-18)
JULY 12, 2011 (continued) A-18wMINI-FOCUS: ADIPOSE INFLAMMATION AND CARDIAC DISEASE238TNF- Causes Endothelial Dysfunction in Small Arteries of Obese SubjectsAgostino Virdis, Ferruccio Santini, Rocchina Colucci, Emiliano Duranti, Guido Salvetti, Ilaria Rugani,
Cristina Segnani, Marco Anselmino, Nunzia Bernardini, Corrado Blandizzi, Antonio Salvetti, Aldo Pinchera,
Stefano Taddei
Virdis and colleagues investigated the causes of endothelial dysfunction seen in obese subjects.
Small arteries from obese and control subjects were isolated from a visceral fat biopsy. Vessels
from obese subjects displayed a blunted relaxation to acetylcholine and a reduced inhibitory
effect of the nitric oxide synthase inhibitor N-nitro-L-argininemethylester. These alterations
ere normalized by the superoxide scavenger tempol or the tumor necrosis factor (TNF)-
inhibitor infliximab. Further studies showed enhanced TNF- expression and TNF-
localization in the vascular media of obese subjects. These findings suggest that TNF- is an
important cause of endothelial dysfunction in obese subjects.MINI-FOCUS: ADIPOSE INFLAMMATION AND CARDIAC DISEASE248Pathologic Changes in Epicardial Fat MacrophagesYoichiro Hirata, Minoru Tabata, Hirotsugu Kurobe, Tatsuo Motoki, Masashi Akaike, Chika Nishio,
Mayuko Higashida, Hiroaki Mikasa, Yutaka Nakaya, Shuichiro Takanashi, Takashi Igarashi,
Tetsuya Kitagawa, Masataka Sata
Recent studies suggest that obesity-linked diseases may be the result of a chronic
inflammatory state. Adipose tissue macrophages can be either pro-inflammatory, known as
M1, or anti-inflammatory, known as M2. Hirata and colleagues investigated the link between
macrophages in epicardial adipose tissue and atherosclerosis by comparing epicardial and
subcutaneous adipose tissue obtained during cardiac surgery. Infiltration of macrophages and
expression of proinflammatory and anti-inflammatory cytokines were higher in the epicardial
fat of patients with coronary artery disease (CAD) compared with those without CAD. The
ratio of M1/M2 macrophages correlated with the extent and severity of CAD. These results
suggest a pathologic role for M1 macrophages in epicardial fat.
Editorial Comment: Paresh Dandona, Husam Ghanim, Ajay Chaudhuri, p. 256(continued on page A-19)











EINTERVENTIONAL CARDIOLOGY258Rates of Restenosis for the BVS in Small or Large ArteriesRoberto Diletti, Yoshinobu Onuma, Vasim Farooq, Josep Gomez-Lara, Salvatore Brugaletta,
Robert Jan van Geuns, Evelyn Regar, Bernard de Bruyne, Dariusz Dudek, Leif Thuesen, Bernard Chevalier,
Dougal McClean, Stephan Windecker, Robert Whitbourn, Pieter Smits, Jacques Koolen, Ian Meredith,
Dong Li, Susan Veldhof, Richard Rapoza, Hector M. Garcia-Garcia, John A. Ormiston, Patrick W. Serruys
Diletti and colleagues investigated the clinical and angiographic outcomes with a second-
generation bioresorbable everolimus-eluting vascular scaffold (BVS). The pre-procedural
reference vessel diameter (RVD) was mandated to be 2.5 and 3.3 mm, because only a
.0-mm stent was available in the ABSORB (A Bioabsorbable Everolimus-Eluting Coronary
tent System) trial. Post-hoc quantitative angiography showed, however, that the RVD was
2.5 mm in 40% of subjects. At 6 months, there were no significant differences in rates of
ajor adverse cardiac events for arteries 2.5 or 2.5 mm; there were also no differences in
ate lumen loss or percentage lumen area stenosis. The second-generation BVS appears to be
afe in small vessels.HEART FAILURE265Causes of Exercise Intolerance in Patients With HFPEFMark J. Haykowsky, Peter H. Brubaker, Jerry M. John, Kathryn P. Stewart, Timothy M. Morgan,
Dalane W. Kitzman
Exercise intolerance is the primary symptom in patients with heart failure with preserved
ejection fraction (HFPEF). Haykowsky and colleagues performed echocardiogram bicycle
stress tests to determine the mechanisms responsible for reduced aerobic capacity (peak VO2).
atients with a history of HFPEF had reduced peak VO2, reduced peak cardiac output, and
lower calculated arterial-venous oxygen content difference during exercise compared with
ge-matched healthy controls. These results suggest that blunted increases in both the heart’s
bility to increase output and the peripheral muscle’s ability to extract oxygen from the
elivered blood limit exercise tolerance in patients with HFPEF.
ditorial Comment: Mathew S. Maurer, Scott L. Hummel, p. 275(continued on page A-24)
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Kapil Kumar, David L. Hayes, Robert F. Rea, Robert G. Hauser
The Fidelis leads (Medtronic, Minneapolis, Minnesota) are more prone to fracture than other
leads. Morrison and colleagues investigated all-cause mortality in almost 3,000 patients with
either Fidelis leads or the next-generation Quattro ICD leads (Medtronic). No deaths were
associated with 85 Fidelis and 23 Quattro failures. At 4 years, survival was diminished in
patients with Fidelis compared with Quattro leads (81% vs. 84%), but this difference was no
longer significant after baseline risk factor adjustment. Elective removal of nonfailed leads was
performed in 5.1% of Fidelis and 0.9% of Quattro patients. In a conservatively managed
cohort, in whom observation was predominantly utilized, adjusted survival is similar between
patients with Fidelis and Quattro ICD leads.Editorial Comment: Mitchell N. Faddis, p. 284HEART RHYTHM DISORDERS
286ncreased Incidence of J-Point Elevation
in Relatives of Patients Experiencing SADSLaurence M. Nunn, Justine Bhar-Amato, Martin D. Lowe, Peter W. Macfarlane, Pauline Rogers,
William J. McKenna, Perry M. Elliott, Pier D. Lambiase
Nunn and colleagues assessed the prevalence of J-point elevation among the relatives of
patients experiencing sudden arrhythmic death syndrome (SADS). A total of 363 first-degree
relatives from 144 families were evaluated. J-point elevation in the inferolateral leads was
present in 23% of relatives and 11% of control subjects (odds ratio: 2.54). These results
suggest that early repolarization is an important, potentially inheritable, pro-arrhythmic trait
or marker of pro-arrhythmia in SADS.(continued on page A-30)
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David S. Siscovick, Bryan Kestenbaum
Linefsky and colleagues measured serum levels of phosphate, calcium, parathyroid hormone,
and 25-hydroxyvitamin D in 1,938 Cardiovascular Health Study participants. All participants
underwent echocardiography measurements of aortic valve sclerosis (AVS), mitral annular
calcification (MAC), and aortic annular calcification (AAC). Each 0.5 mg/dl higher serum
phosphate concentration was associated with a greater adjusted odds of AVS, MAC, and
AAC. In contrast, serum calcium, parathyroid hormone, and 25-hydroxyvitamin D
concentrations were not associated with aortic or mitral calcification. Higher serum phosphate
levels, but still within the normal range, are associated with valvular and annular calcification,
suggesting that phosphate may be a novel risk factor for calcific aortic valve disease.Editorial Comment: Nalini M. Rajamannan, p. 298PULMONARY HYPERTENSION300Iron Deficiency Common, Possibly Pathologic, in IPAHChristopher J. Rhodes, Luke S. Howard, Mark Busbridge, Damien Ashby, Eumorfia Kondili,
J. Simon R. Gibbs, John Wharton, Martin R. Wilkins
Rhodes and colleagues investigated the prevalence and clinical relevance of iron deficiency in
patients with idiopathic pulmonary arterial hypertension (IPAH). Iron deficiency was defined
by raised levels of soluble transferrin receptor (sTfR). Circulating sTfR levels were elevated in
63% of IPAH patients. Iron, ferritin, and transferrin saturation levels were all reduced, but
most did not have anemia. Hepcidin, which inhibits the dietary absorption of iron, was
inappropriately raised in IPAH. sTfR correlated negatively with exercise capacity. Iron
deficiency is common in IPAH patients and associated with disease severity.
